arrow_back Back to App

Support for Rare Disease Day: Raising Awareness and Research

This House Resolution expresses support for designating February 28 as Rare Disease Day. The aim is to increase public awareness of these conditions, encourage early diagnosis, and support global efforts in finding effective treatments and diagnostics. Citizens with rare diseases and their families can expect greater support in accessing information and potential therapies.
Key points
Designating February 28 as Rare Disease Day aims to raise awareness about these conditions affecting millions of Americans.
The resolution emphasizes the importance of early and accurate diagnosis, which can improve the quality of life for individuals with rare diseases.
National and international efforts to develop new drugs, diagnostics, and treatments are supported, offering hope for better prospects for patients.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_181
Sponsor: Rep. Carson, Andre [D-IN-7]
Process start date: 2023-02-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of February 28, 2023, as "Rare Disease Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_181.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-02-28.

What are the main provisions?

Key points include:

  • Designating February 28 as Rare Disease Day aims to raise awareness about these conditions affecting millions of Americans.
  • The resolution emphasizes the importance of early and accurate diagnosis, which can improve the quality of life for individuals with rare diseases.
  • National and international efforts to develop new drugs, diagnostics, and treatments are supported, offering hope for better prospects for patients.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Carson, Andre [D-IN-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health